a clinical stage company, which engages in the research and development of therapies for cancer patients
Industry Biotechnology
A.I.dvisor indicates that over the last year, ALXO has been loosely correlated with MRNA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ALXO jumps, then MRNA could also see price increases.
Ticker / NAME | Correlation To ALXO | 1D Price Change % | ||
---|---|---|---|---|
ALXO | 100% | -0.75% | ||
MRNA - ALXO | 38% Loosely correlated | -5.62% | ||
ARVN - ALXO | 37% Loosely correlated | -1.66% | ||
MDXG - ALXO | 36% Loosely correlated | +23.56% | ||
BPMC - ALXO | 36% Loosely correlated | -1.27% | ||
QSI - ALXO | 35% Loosely correlated | -1.52% | ||
More |